Search filters

List of works by Norikazu Masuda

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: clinical results with a median follow-up of 26 months

scientific article

A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using interstitial brachytherapy: treatment planning and quality assurance

scientific article published on 4 June 2015

A NHO network surveillance for constructing the safe handling system of hazardous drugs in Japan (2nd report)

scientific article published on 01 October 2017

A case of disease-free survival of liver and lung metastases of rectal cancer resected for a total of five times

scientific article published in October 2004

A case of lymph node recurrence after curative operation of type 4 gastric cancer, successfully treated with TS-1

scientific article published on October 1, 2003

A case of metastatic gastric cancer treated with CDDP plus TS-1 and surgical resection

scientific article published in November 2002

A case of unknown primary squamous cell carcinoma in the neck showing a high response with combined chemotherapy including nedaplatin, adriamycin and 5-fluorouracil

scientific article published in August 2005

A case report of hepatocellular carcinoma with portal thrombus responding to hepatic arterial infusion chemo-lipiodolization

scientific article published in November 2002

A case report of inoperable gastric cancer demonstrating a clinical CR after chemo-radiation therapy employing weekly DOC

scientific article published in November 2007

A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer

scientific article

A multicenter phase II trial of neoadjuvant letrozole plus low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer (JBCRG-07): therapeutic efficacy and clinical implications of circulating endothelial cells

scientific article published on 7 May 2018

A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study) ⬇️

scientific article published on July 26, 2012

A new era of preoperative chemotherapy for breast cancer; optimal treatment strategy for patients with residual tumor

scientific article published on 01 October 2017

A phase I/II trial of olaparib tablet in combination with eribulin in Japanese patients with advanced or metastatic triple-negative breast cancer previously treated with anthracyclines and taxanes

scientific article published on 28 January 2019

A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy

scientific article published on 2 August 2011

A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017

scientific article published on 24 July 2012

A randomized study comparing docetaxel/cyclophosphamide (TC), 5-fluorouracil/epirubicin/cyclophosphamide (FEC) followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer

scientific article published on 13 March 2020

A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer

scientific article published on 17 January 2020

A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer

scientific article

A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PREC

scientific article published on 01 September 2018

Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel

scientific article published in November 2013

Adjuvant Capecitabine for Breast Cancer

scientific article published on 01 August 2017

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

scientific article published on June 2017

Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial

scientific article published on 01 January 2021

An icteric type hepatocellular carcinoma with no detectable tumor in the liver: report of a case

scientific article published on 01 January 2006

Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.

scientific article published on 12 September 2012

Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3

scientific article published on 21 October 2020

Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer

Bevacizumab plus paclitaxel versus placebo plus paclitaxel as first-line therapy for HER2-negative metastatic breast cancer (MERiDiAN): A double-blind placebo-controlled randomised phase III trial with prospective biomarker evaluation

scientific article published on 4 November 2016

Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

scientific article published on 12 February 2018

Breast cancer subtype and distant recurrence after ipsilateral breast tumor recurrence

scientific article published on 06 January 2013

Breast metastasis from rectal cancer with BRAF V600E mutation: a case report with a review of the literature

scientific article published on 03 September 2019

Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.

scientific article

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

scientific article

Capecitabine and paclitaxel combination chemotherapy for inoperable or recurrent breast cancer: a phase I dose-finding study by the Kinki Breast Cancer Study Group

scientific article published on 20 July 2007

Capecitabine for primary breast cancer

scientific article published on 6 December 2017

Case report of a dose-volume histogram analysis of rib fracture after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility study

scientific article published on 30 June 2018

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication

scientific article published on 27 February 2019

Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer

scientific article published on 8 February 2017

Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: a multi-institutional study

scientific article published on 01 October 2019

Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population

scientific article published in July 2010

Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy ⬇️

scientific article

Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor

scientific article published on 15 August 2009

Clinicopathological Factors Related to the Prognosis of Metastatic Breast Cancer Patients after Development of Brain Metastasis

scientific article published on 2 December 2015

Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.

scientific article

Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study ⬇️

scientific article published on April 16, 2013

Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer.

scientific article published on 5 January 2018

Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry

scientific article published on 01 October 2002

Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 s

scientific article published on 12 January 2017

Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG.

scientific article

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer

scientific article published on 27 October 2017

Computed radiography-based mammography with 50-microm pixel size: intra-individual comparison with film-screen mammography for diagnosis of breast cancers

scientific article published on 2 April 2009

Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer

scientific article published on 01 September 2019

Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study

scientific article published on 20 November 2017

Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized cont

scientific article published on 08 June 2020

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2.

scientific article published on 26 October 2015

Current activities and perspective of JBCRG (Japan Breast Cancer Research Group)

scientific article published on 01 September 2012

Current situation and issues regarding preoperative chemotherapy for HER2-positive breast cancer

scientific article published on December 1, 2012

Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.

scientific article published on March 2005

Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting

scientific article published in April 2015

Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence

scientific article published on 02 July 2016

Differential Involvement of Autophagy and Apoptosis in Response to Chemoendocrine and Endocrine Therapy in Breast Cancer: JBCRG-07TR

scientific article published on 24 February 2019

Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer

scientific article

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples

scientific article published on 16 September 2019

Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer ⬇️

scientific article published on July 1, 2011

Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial

scientific article

Durable complete response in HER2-positive breast cancer: a multicenter retrospective analysis.

scientific article published on 11 September 2017

Effectiveness of chemoradiotherapy for three cases of squamous cell anal carcinoma

scientific article published in October 2004

Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial

scientific article published on 8 April 2010

Efficacy and safety of ixabepilone in taxane-resistant patients with metastatic breast cancer previously treated with anthracyclines: results of a phase II study in Japan

scientific article published on 28 March 2013

Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial

scientific article published on 22 December 2016

Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.

scientific article

Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study)

scientific article published on 24 August 2020

Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study

scientific article

Erratum to: Outcomes of trastuzumab therapy in HER2‑positive early breast cancer patients

scientific article published on 01 August 2015

Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.

scientific article published in July 2017

Evaluating the 21-gene assay Recurrence Score® as a predictor of clinical response to 24 weeks of neoadjuvant exemestane in estrogen receptor-positive breast cancer

scientific article published on 8 October 2013

Evaluation of ALDH1 expression in ipsilateral breast cancer recurrence

scientific article

Evaluation of prophylactic hepatic arterial infusion chemotherapy after curative hepatectomy for metastatic colorectal cancer

scientific article published in October 2004

Evaluation of suspicious nipple discharge by magnetic resonance mammography based on breast imaging reporting and data system magnetic resonance imaging descriptors

scientific article

Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer

scientific article published on 15 August 2015

Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article published on 14 April 2014

Everolimus plus exemestane as first-line therapy in HR⁺, HER2⁻ advanced breast cancer in BOLERO-2.

scientific article published on 21 December 2013

Everolimus plus exemestane in postmenopausal patients with estrogen-receptor-positive advanced breast cancer - Japanese subgroup analysis of BOLERO -2

scientific article published on January 2015

Examination about the influence for daily life that nail and skin disorders induced by docetaxel in patients with breast cancer

scientific article published in April 2009

Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria

scientific article published on 20 August 2015

Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study

scientific article published on 06 December 2019

Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study.

scientific article published on 2 November 2017

Final results of a safety and efficacy trial of preoperative sequential chemoradiation therapy for the nonsurgical treatment of early breast cancer: Japan Clinical Oncology Group Study JCOG0306.

scientific article published on 12 November 2013

First-line bevacizumab in combination with weekly paclitaxel for metastatic breast cancer: efficacy and safety results from a large, open-label, single-arm Japanese study

scientific article published on 31 July 2011

First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial.

scientific article published on 2 February 2017

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind

scientific article

Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.

scientific article published on 13 June 2017

Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy

scientific article published on 02 August 2019

Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies

scientific article published on 12 March 2020

High expression of two genes selected by iAFLP: a new prognostic factor of estrogen receptor-positive breast cancer

scientific article published on 01 August 2004

Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.

scientific article

Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial.

scientific article published on 14 February 2018

Intensive vs. Standard Post-Operative Surveillance in High-Risk Breast Cancer Patients (INSPIRE): Japan Clinical Oncology Group Study JCOG1204.

scientific article published on 5 August 2015

Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma

scientific article published in January 2005

Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition

scientific article published on 10 February 2011

Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.

scientific article published on 28 May 2009

Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer

scientific article published on 05 March 2020

Longitudinal practical measurement of skin color and moisture during and after breast-conserving therapy: influence of neoadjuvant systemic therapy

scientific article published on 27 October 2009

Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609 ⬇️

scientific article published on January 20, 2013

Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers

scientific article published on 16 October 2007

MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy.

scientific article published on 03 June 2017

Male Breast Cancer Originating in an Accessory Mammary Gland in the Axilla: A Case Report ⬇️

scientific article published on January 1, 2012

Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3

scientific article published on 21 September 2020

Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay

scientific article published on 7 April 2009

Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer ⬇️

scientific article published on 08 January 2011

Multicenter study of primary systemic therapy with docetaxel, cyclophosphamide and trastuzumab for HER2-positive operable breast cancer: the JBCRG-10 study

scientific article published on 01 January 2020

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial ⬇️

scientific article published on January 20, 2012

Neoadjuvant endocrine therapy with exemestane followed by response-guided combination therapy with low-dose cyclophosphamide in postmenopausal patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study

scientific article published on 14 June 2018

Neoadjuvant exemestane or exemestane plus docetaxel and cyclophosphamide tailored by clinicopathological response to 12 weeks' exemestane exposure in patients with estrogen receptor-positive breast cancer: A multicenter, open-label, phase II study

scientific article published on 30 July 2019

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial

scientific article published on 17 July 2020

Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer

scientific article published on 29 May 2019

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

scientific article

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer

scientific article published on 24 May 2019

Objective Assessment of Dermatitis Following Post-operative Radiotherapy in Patients with Breast Cancer Treated with Breast-conserving Treatment ⬇️

scientific article published on 08 November 2010

Objective and longitudinal assessment of dermatitis after postoperative accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy in patients with breast cancer treated with breast conserving therapy: reduction of moistu ⬇️

scientific article published on 06 October 2010

Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodes

scientific article published on 16 July 2014

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

scientific article published on 4 June 2017

Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis

scientific article published on 29 May 2020

Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study

scientific article

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients

scientific article published on 10 February 2015

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01

scientific article published on 14 February 2020

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial

scientific article published on 23 October 2020

PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocr

scientific article published on 11 April 2017

Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid

journal article published in 2013

Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results

scientific article

Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study.

scientific article published in May 2019

Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients

scientific article published on 03 November 2018

Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: a Japanese phase II study.

scientific article published on 18 January 2018

Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients

scientific article published on 04 December 2018

Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies

scientific article published on 25 July 2018

Palbociclib-letrozole as first-line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study

scientific article published on 18 May 2020

Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial

scientific article published on 22 August 2019

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

scientific article published on 01 December 2020

Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study

scientific article

Phase I study of combination therapy with weekly paclitaxel and cyclophosphamide for advanced or recurrent breast cancer

scientific article published on 19 September 2009

Phase I trial of afatinib plus vinorelbine in Japanese patients with advanced solid tumors, including breast cancer.

scientific article

Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer.

scientific article

Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B ⬇️

scientific article published on November 29, 2011

Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes

scientific article

Phase II study of preoperative sequential FEC and docetaxel predicts of pathological response and disease free survival

scientific article published on 19 September 2007

Phase II trial in Japan of sequential administration of weekly paclitaxel followed by FEC as neoadjuvant chemotherapy for locally advanced breast cancer [KBCSG0206 trial: Kinki Breast Cancer Study Group (KBCSG)].

scientific article published on 2 July 2010

Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy

scientific article

Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study

scientific article published in June 2010

Phase III randomized trial of toremifene versus tamoxifen for Japanese postmenopausal patients with early breast cancer

scientific article published on 12 September 2012

Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

scientific article published on 15 September 2016

Prediction of postoperative disease-free survival and brain metastasis for HER2-positive breast cancer patients treated with neoadjuvant chemotherapy plus trastuzumab using a machine learning algorithm

scientific article published on 07 September 2018

Predictive factors for anthracycline-based chemotherapy for human breast cancer

scientific article published on 06 August 2009

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients.

scientific article published on July 2010

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3

Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor–positive/human epidermal growth factor receptor 2–negative metastatic breast cancer in PALOMA-3

scientific article published in Novemer 2018

Preliminary result of accelerated partial breast irradiation after breast-conserving surgery

scientific article published on 20 September 2008

Preoperative u-PAR gene expression in bone marrow indicates the potential power of recurrence in breast cancer cases

scientific article published on 30 April 2009

Primary chest wall abscess mimicking a breast tumor that occurred after blunt chest trauma: a case report.

scientific article published on 09 February 2014

Primary signet-ring cell carcinoma of the colon and rectum: report of eight cases and review of 154 Japanese cases

scientific article

Probiotic Beverage with Soy Isoflavone Consumption for Breast Cancer Prevention: A Case-control Study

scientific article published on August 2013

Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis

scientific article published on 21 December 2014

Prognostic significance of subtype and pathologic response in operable breast cancer; a pooled analysis of prospective neoadjuvant studies of JBCRG.

scientific article published on 14 December 2013

Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study).

scientific article published on 17 December 2008

Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).

scientific article published on 21 February 2018

Randomized phase II study of nab-paclitaxel as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.

scientific article

Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer.

scientific article

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

scientific article published on 12 April 2014

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

scientific article published on 19 August 2009

Randomized study of taxane versus TS-1 in women with metastatic or recurrent breast cancer (SELECT BC).

scientific article published on 12 May 2010

Rechallenge of anti-PD-1/PD-L1 antibody showed a good response to metastatic breast cancer: a case report

scientific article published on 23 November 2020

Relationship between body mass index and preoperative treatment response to aromatase inhibitor exemestane in postmenopausal patients with primary breast cancer ⬇️

scientific article published on August 19, 2011

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial)

scientific article published on 01 December 2020

Repeat lumpectomy for ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: the impact of radiotherapy on second IBTR.

scientific article published on 13 March 2013

Results of survey conducted on perioperative chemotherapy and supportive care in primary breast cancer (JBCRG01)

scientific article published in October 2007

Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer

scientific article published on 03 July 2020

Role of percutaneous transhepatic biliary drainage in patients with obstructive jaundice caused by local recurrence of gastric cancer

scientific article

Safety Evaluation of Trastuzumab Emtansine in Japanese Patients with HER2-Positive Advanced Breast Cancer

scientific article

Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study

scientific article published on 8 September 2016

Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer

scientific article

Stratifying the outcome after neoadjuvant treatment using pathological response classification by the Japanese Breast Cancer Society

scientific article published on 30 September 2015

Study of low-dose capecitabine monotherapy for metastatic breast cancer

scientific article published on 21 April 2010

Surgical indication and significance of local therapy for first pulmonary metastases from colorectal cancer

scientific article published on 01 October 2003

Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational

scientific article published on 05 July 2018

Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society

scientific article published on 20 July 2019

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor-Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy-MONARCH 2: A Randomized Clinical Trial

scientific article published on 29 September 2019

The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy

scientific article published on 10 September 2014

The efficacy and safety of FSK0808, filgrastim biosimilar: a multicenter, non-randomized study in Japanese patients with breast cancer

scientific article published on 14 July 2013

The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI study

scientific article published on 13 September 2020

The novel germline mutation of hMSH2 gene in a case of a colon cancer patient without family history.

scientific article published in July 2002

The present state and perception of young women with breast cancer towards breast reconstructive surgery

scientific article published in July 2014

Topoisomerase IIalpha-positive and BRCA1-negative phenotype: association with favorable response to epirubicin-based regimens for human breast cancers

scientific article

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inf

scientific article published on 07 May 2020

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

scientific article published on 9 August 2014

Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ

scientific article published on 20 April 2017

Uncertainty of cosmetic evaluation after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility study.

scientific article published on 4 May 2017

Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in Japan

scientific article

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study.

scientific article published on 21 September 2018

Widespread subdural metastasis from breast cancer progressing rapidly with cerebral herniation: A case report

scientific article

[A Case of Recurrent Breast Cancer with Adrenal Metastasis Resected Using Laparoscopic Surgery]

scientific article published on 01 November 2016

[A case of long-term survival with recurrence leiomyosarcoma of the rectum treated by repeated local resections]

scientific article published on 01 October 2004

[A case of successful resection for recurrent intraductal papillary mucinous adenocarcinoma]

scientific article published on 01 October 2005

[Current status and future perspectives for the treatment of triple-negative breast cancer in Japan]

scientific article published on 01 April 2012

[Effect of oral dexamethasone given 24 hours previously on docetaxel-induced edema: a retrospective study]

[Limits of surgical therapy for pulmonary metastasis from breast cancer]

scientific article published on 01 November 2002

[Mohs paste for unresectable local lesion of breast cancer]

scientific article published on 01 September 2008

[Optimal chemotherapy for advanced and recurrent breast cancer patients]

scientific article published on 01 June 2007

[Outpatient chemotherapy for breast cancer patients]

scientific article published on 01 June 2007

[Therapeutic effect of rebamipide for oral mucositis associated with FEC therapy for breast cancer]

scientific article published on 01 November 2014

[Ⅰ.Capecitabine for Adjuvant Therapy in Breast Cancer]

scientific article published on 01 December 2020

Paulina is supported by:

About Paulina

Help